Professor Fred Binka Proposes Splitting FDA into Independent Food and Drug Regulatory Authorities

Professor Fred Binka, a distinguished clinical epidemiologist, has called for a significant restructuring of Ghana’s Food and Drugs Authority (FDA) by splitting it into two distinct regulatory bodies. Speaking at the opening of the 2026 West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) Research Conference at the University of Ghana, Prof. Binka argued that the current unified structure is overstretched. He contended that separating food safety from drug regulation would allow for more specialized and effective oversight, ensuring that both sectors receive the dedicated attention required to protect public health.

During his address, Prof. Binka emphasized that the scale and complexity of current food safety issues in Ghana are becoming overwhelming for a single entity to manage. He highlighted a critical need for more trained bioscientists to actively monitor food safety standards across the nation. To address logistical and technical bottlenecks, the Professor suggested that the FDA should modernize its approach by outsourcing complex laboratory tests to certified academic and research institutions, specifically naming the Noguchi Memorial Institute for Medical Research and WACCBIP as ideal partners for such collaborations.

The 2026 WACCBIP Research Conference, themed "African Bioscience at the interface of health, disease and environment," serves as a vital platform for tackling modern challenges including infectious diseases, climate change, and biotechnology. Prof. Binka’s proposal reflects a growing sentiment within the scientific community that specialized governance is necessary to keep pace with rapid advancements in bioscience. If implemented, this reform could lead to a more robust regulatory framework, ultimately enhancing the safety and quality of both the food and pharmaceutical products consumed by Ghanaians.